Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.

Dettagli Bibliografici
Autori principali: Reilly, J, McMullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Mikhaeel, G, Gilleece, M, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Harrison, C
Natura: Journal article
Lingua:English
Pubblicazione: 2014